4//SEC Filing
Ragard John Phillip 4
Accession 0001641172-25-002183
CIK 0000926617other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:42 PM ET
Size
7.8 KB
Accession
0001641172-25-002183
Insider Transaction Report
Form 4
Ragard John Phillip
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-31−4,843→ 4,844 total→ Common Stock (4,843 underlying) - Exercise/Conversion
Common Stock
2025-03-31+4,843→ 129,890 total
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,843 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
- [F3]On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,843 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.
Documents
Issuer
Aspira Women's Health Inc.
CIK 0000926617
Entity typeother
Related Parties
1- filerCIK 0002031593
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 6:42 PM ET
- Size
- 7.8 KB